PGC1α in the kidney

MR Lynch, MT Tran, SM Parikh - American Journal of …, 2018 - journals.physiology.org
Acute kidney injury (AKI) arising from diverse etiologies is characterized by mitochondrial
dysfunction. The peroxisome proliferator-activated receptor γ coactivator-1alpha (PGC1α), a …

Regulation of glucose and lipid metabolism in health and disease

L Chen, XW Chen, X Huang, BL Song, Y Wang… - Science China life …, 2019 - Springer
Glucose and fatty acids are the major sources of energy for human body. Cholesterol, the
most abundant sterol in mammals, is a key component of cell membranes although it does …

[HTML][HTML] Mitochondrial dysfunction and insulin resistance: an update

MK Montgomery, N Turner - Endocrine connections, 2015 - ec.bioscientifica.com
Mitochondrial dysfunction has been implicated in the development of insulin resistance (IR);
however, a large variety of association and intervention studies as well as genetic …

Targeting hepatic glucose metabolism in the treatment of type 2 diabetes

AK Rines, K Sharabi, CDJ Tavares… - Nature reviews Drug …, 2016 - nature.com
Type 2 diabetes mellitus is characterized by the dysregulation of glucose homeostasis,
resulting in hyperglycaemia. Although current diabetes treatments have exhibited some …

A mitochondrial SCF‐FBXL4 ubiquitin E3 ligase complex degrades BNIP3 and NIX to restrain mitophagy and prevent mitochondrial disease

Y Cao, J Zheng, H Wan, Y Sun, S Fu, S Liu, B He… - The EMBO …, 2023 - embopress.org
Mitophagy is a fundamental quality control mechanism of mitochondria. Its regulatory
mechanisms and pathological implications remain poorly understood. Here, via a …

[HTML][HTML] Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition

A Cruz-Bermúdez, R Laza-Briviesca… - Free Radical Biology …, 2019 - Elsevier
Background Platinum-based chemotherapy remains the standard of care for most lung
cancer cases. However chemoresistance is often developed during the treatment, limiting …

[HTML][HTML] Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases

L Qian, Y Zhu, C Deng, Z Liang, J Chen… - … and Targeted Therapy, 2024 - nature.com
Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family (PGC-1s),
consisting of three members encompassing PGC-1α, PGC-1β, and PGC-1-related …

Peroxisom proliferator-activated receptor-γ coactivator-1α in neurodegenerative disorders: A promising therapeutic target

YN Yang, MQ Zhang, FL Yu, B Han, MY Bao… - Biochemical …, 2023 - Elsevier
Neurodegenerative disorders (NDDs) are characterized by progressive loss of selectively
vulnerable neuronal populations and myelin sheath, leading to behavioral and cognitive …

Melatonin/PGC1A/UCP1 promotes tumor slimming and represses tumor progression by initiating autophagy and lipid browning

W Xiao, Z Xiong, W Xiong, C Yuan… - Journal of Pineal …, 2019 - Wiley Online Library
Metabolic adaptations are emerging hallmarks of cancer progression and cellular
transformation. Clear cell renal cell carcinoma (ccRCC) is a metabolic disease defined …

PGC‐1α, a potential therapeutic target against kidney aging

G Lee, MJ Uddin, Y Kim, M Ko, I Yu, H Ha - Aging cell, 2019 - Wiley Online Library
Aging is defined as changes in an organism over time. The proportion of the aged
population is markedly increasing worldwide. The kidney, as an essential organ with a high …